Header
Header
Article

New patent for JAZZ drug XYWAV – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for JAZZ drug XYWAV


Annual Drug Patent Expirations for XYWAV

Xywav is a drug marketed by Jazz and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

Drug patent litigation for XYWAV.

This drug has fifty-three patent family members in twenty-five countries.

The generic ingredient in XYWAV is calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate. One supplier is listed for this compound. Additional details are available on the calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for JAZZ drug XYWAV



Source link

Back to top button